Variety of qualified sufferers: CDEC talked about the uncertainty in the quantity of sufferers with moderately intense to critical hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical gurus consulted by CADTH indicated that some clients that are categorized as possessing mild or moderate illness may have a severe bleeding phenoty… Read More